|
ANKHD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.76381131922199E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.71003228138989E-12 |
| Normal-vs-Stage2 |
2.12450000000031E-05 |
| Normal-vs-Stage3 |
1.27409194305983E-12 |
| Normal-vs-Stage4 |
9.86050000539862E-08 |
| Stage1-vs-Stage2 |
8.244400E-01 |
| Stage1-vs-Stage3 |
1.410430E-01 |
| Stage1-vs-Stage4 |
7.322000E-01 |
| Stage2-vs-Stage3 |
3.087000E-01 |
| Stage2-vs-Stage4 |
6.789200E-01 |
| Stage3-vs-Stage4 |
4.823200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.65973959207622E-15 |
| Normal-vs-AfricanAmerican |
4.944400E-03 |
| Normal-vs-Asian |
8.0862000428894E-09 |
| Caucasian-vs-AfricanAmerican |
6.975600E-02 |
| Caucasian-vs-Asian |
7.938400E-01 |
| AfricanAmerican-vs-Asian |
1.412390E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.02830024682066E-10 |
| Normal-vs-Female |
1.93745020027336E-12 |
| Male-vs-Female |
6.892800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.74870184577981E-11 |
| Normal-vs-Age(41-60Yrs) |
1.5063950087324E-11 |
| Normal-vs-Age(61-80Yrs) |
1.1205000260972E-09 |
| Normal-vs-Age(81-100Yrs) |
9.574800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.659400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.603000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.002400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.381600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.325000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.817600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.261930E-03 |
| Classical-VS-Follicular |
8.538600E-01 |
| Classical-VS-Other |
1.789830E-01 |
| Classical-VS-Normal |
2.79239964484645E-11 |
| Tall-VS-Follicular |
1.100120E-02 |
| Tall-VS-Other |
9.743200E-01 |
| Tall-VS-Normal |
1.66290314851381E-11 |
| Follicular-VS-Other |
2.629800E-01 |
| Follicular-VS-Normal |
1.39479999994307E-07 |
| Other-VS-Normal |
4.172900E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.06480047001867E-10 |
| Normal-vs-N1 |
1.55120000178144E-08 |
| N0-vs-N1 |
6.374400E-01 |
|
|
